Ovary Removal Before Menopause Linked to Cognitive Impairment, Dementia Risk

Health & LifestyleNews
650

Listen to article (english)

Translate to Spanish or other 102 languages!

A new study shows that ovary removal before menopause is linked to decreased white matter in the brain later in life. Image for illustration purposes
A new study shows that ovary removal before menopause is linked to decreased white matter in the brain later in life. Image for illustration purposes

Medical News Today

- Advertisement -
  • A new study examined the brains of females who underwent full ovary removal before going through menopause.
  • Sometimes, females must undergo this type of procedure to treat conditions such as ovarian cancer or endometriosis.
  • The study’s findings show that females who undergo ovary removal before menopause have a decrease in white matter in their brains later in life. 
  • A decrease in white matter is linked to cognitive impairment.

A new study examined the cognitive effects of ovary removal in females.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/ovary-removal-before-menopause-cognitive-decline-dementia-risk?slot_pos=article_2&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-06-28&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Postpartum Urinary Incontinence Linked to Mental Health
Next article
Work-Related Nerve Injuries are Common with Repetitive Motions

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -